Thats not huge, but thanks to the softwares rapid adoption, investors are betting big: OpenEvidence has raised $210 million led by GV (Googles venture arm) and Kleiner Perkins at a valuation of $3.5 billion, up from $1 billion at its last financing in February, Nadler told Forbes
F.ShenL
Weight loss from these medications may indirectly influence lipid profiles, but individual responses vary significantly based on baseline metabolic health and genetic factors
PMID: 41318751 6 A case of atypical systemic primary carnitine deficiency in Saudi Arabia
Porter C, Constantin-Teodosiu D, Constantin D, Leighton B, Poucher SM, Greenhaff PL
Recurrent hypoglycaemic episodes necessitate urgent medication reviewdose reduction of insulin or sulfonylureas is typically required rather than discontinuation of Ozempic